Targeted delivery using peptide-functionalised gold nanoparticles to white adipose tissues of obese rats

Obesity is a complex metabolic disease of excessive fat accumulation. It is a worldwide epidemic affecting billions of people. Current pharmacological treatment of obesity remains limited and ineffective due to systemic drug toxicity and undesirable side effects. The current epidemic raises a serious need for development of safer drugs to treat obesity. Nanotechnology-based drug delivery system for administering pharmaceutical compound to achieve therapeutic effects is currently an exciting field in cancer treatment. Drug delivery involves either modification of drug release profile, absorption, distribution and/or elimination, for the benefit of improving drug efficacy and safety. Therefore, nanotechnology holds promise in the treatment of diseases including obesity. Gold nanoparticles (GNPs) functionalised with different biomolecules have been successfully used as drug delivery, labelling and imaging tools in biomedical research. In this study, the binding-specificity and targeting ability of adipose homing peptide (AHP)-functionalised GNPs (AHP-GNPs) were evaluated using flow cytometry and inductively coupled plasma-optical emission spectroscopy. Caco-2 cells and rats fed either chow or a high-fat diet were treated with either unfunctionalised GNPs or AHP-GNPs. Cellular uptake of GNPs was detected in cells treated with AHP-GNPs and not those treated with GNPs alone. Binding of AHP to cells was both temperature- and concentration-dependent. Compared to rats treated with GNPs alone, treatment of obese rats with AHP-GNPs resulted in the targeted delivery of the GNPs to the white adipose tissue (WAT). This paper reports the successful targeting of AHP-functionalised GNPs to WAT of obese rats.

[1]  A. Bhunia,et al.  WST-1-based cell cytotoxicity assay as a substitute for MTT-based assay for rapid detection of toxigenic Bacillus species using CHO cell line. , 2008, Journal of microbiological methods.

[2]  Vincent M Rotello,et al.  Gold nanoparticles in delivery applications. , 2008, Advanced drug delivery reviews.

[3]  U. Settmacher,et al.  Bariatric surgery to treat obesity. , 2013, Seminars in nephrology.

[4]  Robert Langer,et al.  Impact of nanotechnology on drug delivery. , 2009, ACS nano.

[5]  J. Flier,et al.  Adipose Tissue as an Endocrine Organ , 2014 .

[6]  C. Fan,et al.  Gold nanoparticlebased optical probes for target-responsive DNA structures , 2008 .

[7]  Kristen Lyons,et al.  NANOTECHNOLOGY: THE NEXT CHALLENGE FOR ORGANICS , 2008 .

[8]  D. Langin.  Adipose tissue lipolysis as a metabolic pathway to define pharmacological strategies against obesity and the metabolic syndrome. , 2006, Pharmacological research.

[9]  Xiu Shen,et al.  In vivo renal clearance, biodistribution, toxicity of gold nanoclusters. , 2012, Biomaterials.

[10]  Ghulam Murtaza,et al.  Gold Nanoparticles: Synthesis and Applications in Drug Delivery , 2014 .

[11]  G. Bray,et al.  Pharmacological Treatment of the Overweight Patient , 2007, Pharmacological Reviews.

[12]  C. Soto,et al.  Bioaccumulation and toxicity of gold nanoparticles after repeated administration in mice. , 2010, Biochemical and biophysical research communications.

[13]  A. Popovtzer,et al.  Targeted gold nanoparticles enable molecular CT imaging of cancer: an in vivo study , 2011, International journal of nanomedicine.

[14]  U. Feldt-Rasmussen,et al.  Obesity: the new worldwide epidemic threat to general health and our complete lack of effective treatment. , 2004, Endocrinology.

[15]  Hao Hong,et al.  Applications of gold nanoparticles in cancer nanotechnology. , 2008, Nanotechnology, science and applications.

[16]  H. Harashima,et al.  Ligand-based targeted delivery of a peptide modified nanocarrier to endothelial cells in adipose tissue. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[17]  Robert Langer,et al.  Nanotechnology in drug delivery and tissue engineering: from discovery to applications. , 2010, Nano letters.

[18]  J. Beckmann,et al.  Genetic testing in patients with obesity. , 2012, Best practice & research. Clinical endocrinology & metabolism.

[19]  Wadih Arap,et al.  Reversal of obesity by targeted ablation of adipose tissue , 2004, Nature Medicine.

[20]  S. Singh,et al.  Functionalized Gold Nanoparticles and Their Biomedical Applications , 2011, Nanomaterials.

[21]  Beom Seok Han,et al.  Comparison of gene expression profiles in mice liver following intravenous injection of 4 and 100 nm-sized PEG-coated gold nanoparticles. , 2009, Toxicology letters.

[22]  S. Sahoo,et al.  Cancer nanotechnology: application of nanotechnology in cancer therapy. , 2010, Drug discovery today.

[23]  Yong-Qing Yang,et al.  Long Term and Standard Incubations of WST-1 Reagent Reflect the Same Inhibitory Trend of Cell Viability in Rat Airway Smooth Muscle Cells , 2012, International journal of medical sciences.

[24]  Ying Liu,et al.  Characterization of gold nanorods in vivo by integrated analytical techniques: their uptake, retention, and chemical forms , 2010, Analytical and bioanalytical chemistry.

[25]  Keishiro Tomoda,et al.  Biodistribution of colloidal gold nanoparticles after intravenous administration: effect of particle size. , 2008, Colloids and surfaces. B, Biointerfaces.

[26]  Kinam Park.  Nanotechnology: What it can do for drug delivery. , 2007, Journal of controlled release : official journal of the Controlled Release Society.

[27]  O. Dizdar,et al.  Obesity: an endocrine tumor? , 2004, Medical hypotheses.

[28]  F. Bertolini,et al.  Adipose tissue cells, lipotransfer and cancer: a challenge for scientists, oncologists and surgeons. , 2012, Biochimica et biophysica acta.

[29]  Paula Gomes,et al.  Effect of surface coating on the biodistribution profile of gold nanoparticles in the rat. , 2012, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[30]  C. Lavie,et al.  Obesity and cardiovascular disease: risk factor, paradox, and impact of weight loss. , 2009, Journal of the American College of Cardiology.

[31]  Raoul Kopelman,et al.  Targeted gold nanoparticles enable molecular CT imaging of cancer. , 2008, Nano letters.

[32]  N. Khlebtsov,et al.  Gold Nanoparticles in Biology and Medicine: Recent Advances and Prospects , 2011, Acta naturae.

[33]  P. Yarowsky,et al.  Human neural progenitor cells retain viability, phenotype, proliferation, and lineage differentiation when labeled with a novel iron oxide nanoparticle, Molday ION Rhodamine B , 2013, International journal of nanomedicine.

[34]  Weipeng Cao,et al.  Gold nanoparticles functionalized with therapeutic and targeted peptides for cancer treatment. , 2012, Biomaterials.

[35]  M. M. Mady,et al.  Liver uptake of gold nanoparticles after intraperitoneal administration in vivo: A fluorescence study , 2011, Lipids in Health and Disease.

[36]  E. Berry,et al.  Weight control and the management of obesity after menopause: the role of physical activity. , 2003, Maturitas.

[37]  D. Hirst,et al.  Gold nanoparticles as novel agents for cancer therapy. , 2012, The British journal of radiology.

[38]  S. Blair,et al.  Obesity and Cardiovascular Disease , 2006 .

[39]  P. Björntorp,et al.  The role of antidepressants in the treatment of abdominal obesity. , 2000, Medical hypotheses.

[40]  Olga Sirin,et al.  Treatment of obesity as a potential complementary approach to cancer therapy. , 2013, Drug discovery today.

[41]  M. Abdelhalim,et al.  The gold nanoparticle size and exposure duration effect on the liver and kidney function of rats: In vivo. , 2013, Saudi journal of biological sciences.

[42]  Rodney A. Hill,et al.  Gold nanoparticles: the importance of physiological principles to devise strategies for targeted drug delivery. , 2012, Nanomedicine : nanotechnology, biology, and medicine.

[43]  H. Harashima,et al.  Vascular-targeted nanotherapy for obesity: unexpected passive targeting mechanism to obese fat for the enhancement of active drug delivery. , 2012, Journal of controlled release : official journal of the Controlled Release Society.